An Australian first: Newly accredited diagnostic tool to transform diagnosis of children with brain cancer
From December 2022, molecular profiling developed through ANZCHOG’s AIM-BRAIN PROject (Access to Innovative Molecular Diagnostic…
From December 2022, molecular profiling developed through ANZCHOG’s AIM-BRAIN PROject (Access to Innovative Molecular Diagnostic…
From December 2022, molecular profiling developed through ANZCHOG’s AIM-BRAIN PROject (Access to Innovative Molecular Diagnostic…
Australian researchers have developed a new risk scoring system for children with leukaemia based on…